大健康國際(02211.HK)擬折讓約1.23%配發合共3.04億股現有股份 淨籌2435萬港元
格隆匯5月13日丨大健康國際(02211.HK)公吿,於2025年5月13日,公司(作為發行人)與認購人皇御控股有限公司訂立認購協議,據此,認購人已有條件同意認購而公司已有條件同意以現金約2435萬港元配發及發行合共304,402,632股現有股份或30,440,263股合併股份(視情況而定),認購價為每股現有股份0.08港元或每股合併股份0.80港元(視情況而定)。
假設公司已發行股本於本公吿日期至交割日期止期間內並無變動,認購協議項下股份相當於本公吿日期公司現有已發行股本約38.00%;認購價每股現有股份0.08港元較2025年5月13日(即認購協議日期)於聯交所所報每股現有股份收市價0.081港元折讓約1.23%;認購事項所得款項淨額亦約為2435萬港元,相當於每股認購股份淨價約0.08港元或0.80港元(視情況而定)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.